CLINICAL_TRIALS
trial_result
· 2013-06-24
Clinical Trial Update: Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM [Phase 2]
Summary
Phase 2 trial evaluating sorafenib plus protracted temozolomide in recurrent glioblastoma completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Recurrent Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2013-06-24